By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Key Highlights of Chemistry today

Today’s Political Science Science Briefing | March 28th 2026, 1:00:14 pm

Today’s Neurology Science Briefing | March 28th 2026, 1:00:14 pm

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Laboratory Medicine - A New Frontier in Risk Stratification: Cardiac Strain Imaging for Kidney Patients

Laboratory Medicine

A New Frontier in Risk Stratification: Cardiac Strain Imaging for Kidney Patients

Last updated: March 28, 2026 9:00 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

A New Frontier in Risk Stratification: Cardiac Strain Imaging for Kidney Patients

A prospective study published in the Journal of Magnetic Resonance Imaging demonstrates a significant advance in prognostic testing for patients with end-stage renal disease (ESRD). Researchers used 3.0 Tesla cardiac MRI and advanced feature-tracking software to analyze left atrial and left ventricular strain in over 300 patients on dialysis. They found that combining measurements of left atrial reservoir strain and left ventricular global longitudinal strain provided superior predictive power for major adverse cardiovascular events (MACE) compared to traditional clinical risk factors alone. This integration of novel imaging biomarkers resulted in a model with a C-index of 0.79, offering a more precise tool for risk stratification in a high-mortality population where current laboratory medicine and diagnostic algorithms are limited.

Study Significance: This research directly impacts the field of laboratory medicine by showcasing the evolving role of advanced imaging as a complementary diagnostic modality to traditional serum biomarkers like cardiac troponins and BNP. For professionals focused on diagnostic accuracy and prognostic testing, it highlights a pathway toward integrated, multi-parameter risk models. Incorporating such imaging-derived strain data could refine clinical correlation and post-analytical interpretation, leading to more personalized management strategies for complex patients with chronic kidney disease.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Key Highlights
Next Article Key Highlights of Biology today
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Heart failure, diabetes, and a drug’s complex interplay

Liver Biomarkers Predict Mortality in Fontan Circulation Patients

Ferroptosis: A New Frontier in Heart Failure Diagnostics and Therapeutics

A Blood Test for Alzheimer’s Treatment: Plasma Biomarkers Track Lecanemab’s Real-World Impact

Osteopontin: A new placental biomarker for fetal growth restriction

A New Diagnostic Beacon: 18F-NOTA-R49 PET/CT Challenges the FDG Standard in Oncology

Biomarkers in the Breathless: A New Study Validates Diagnostic Accuracy in a High-Mortality Setting

Corrigendum on a Novel Cancer Drug Trial: The Importance of Accurate Data Presentation

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Gastroenterology
  • Social Sciences
  • Surgery
  • Natural Language Processing
  • Cell Biology
  • Engineering
  • Genetics
  • Immunology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?